April 1, 2015 -- SolmeteX is pleased to announce it has successfully completed and passed the ISO 11143:2008 standard through NSF International with 99.965% capture rate on its Hg5 amalgam separator system. This compliments our previous passing of the ISO 11143:1999E with 99.02% capture rate. The current report may be viewed online at www.SolmeteX.com.

As a top-quality manufacturer of amalgam separators within United States and Canada, SolmeteX has been recognized by 16 dental associations as the preferred choice for their members. The Hg5 amalgam separator has received 12 consecutive Townie Choice awards, the 2013 and 2014 “Preferred Products” and a 5+ rating for “Editors’ Choice” by Dental Advisor make it the most awarded amalgam separator on the market. The Hg5 series of amalgam separators are proudly sold through our dealer network across North America.

Questions can be emailed to info@SolmeteX.com.

MELVILLE, N.Y., April 9, 2015 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has been named one of "America's Best Employers" by Forbes in the magazine's inaugural annual ranking. Henry Schein ranked #203 out of 500 organizations ranked by Forbes, based on an independent, anonymous survey of 20,000 employees working at more than 3,500 organizations.

"It is very gratifying to be recognized as one of the best employers in the United States by Forbes, especially since the selection is based on the opinion of employees who represent a company's greatest asset," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "This honor underscores our belief in Henry Schein's values-based culture, which is embraced by 18,000 Team Schein Members around the world and which has driven our growth and success for 83 years. We believe that by fostering an environment built on ethics, open communications, mutual benefit, creativity and recognition of the contributions of all Team Schein Members, we can help ensure that our best years are yet to come."

Forbes"America's Best Employers 2015" Methodology

The top employers comprising the list were chosen by Forbes based on an independent survey conducted by Statista.com. The survey included more than 20,000 American employees working for large U.S. companies and institutions, and U.S. divisions of international firms with at least 2,500 workers in the United States. Respondents were asked anonymously through several online panels how likely they would be to recommend their employer, or any other employer in their industry, to a potential employee. The respondents mirrored the gender, age, region, educational level, and ethnicity of the overall U.S. workforce. More than 3,500 companies were represented in the survey, with Forbes creating a list of the top 500 firms for their April 13, 2015 issue.

More information, including the complete list, can be found at www.forbes.com/best-employers.

Waltham, Mass. -- April 7, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the appointment of Mark B. Carbeau as Chief Executive Officer and Director. Dr. Kenneth S. Kornman, DDS, PhD, who served as the President and CEO since August 2012, will continue to serve as President, Chief Scientific Officer and a Director.

Mr. Carbeau is a transformative healthcare leader who brings to Interleukin more than three decades of business expertise in the life science industries, with a proven track record of building high growth diagnostic and pharmaceutical businesses. Recognized as a visionary entrepreneur, Mr. Carbeau has refined or reinvented corporate strategies and business models to maximize the growth potential of multiple companies. His appointment strengthens the executive leadership team and adds significant commercial and operational expertise.

“On behalf of the Board of Directors of Interleukin Genetics, I am excited to welcome Mark Carbeau to the Company,” said James M. Weaver, Chairman of The Board of Interleukin Genetics. “Mark is a leader with an outstanding track record of building high growth healthcare businesses, including taking multiple products from ideation to commercialization and category leadership. I am confident that under Mark’s leadership the Company will continue to grow and create value for our partners and shareholders.”

Mr. Weaver continued, “I would like to thank Ken for his years of service in the roles of President and CEO. As one of the founders and Chief Scientific Officer of Interleukin, Ken has made many outstanding contributions to the Company, and has been an outspoken proponent of personalized medicine and an industry leader in the research, development and commercialization of genetics-based risk assessment products and services to improve healthcare. We look forward to benefiting from his continued scientific leadership.”

“I welcome the opportunity to lead Interleukin Genetics during this exciting time as we work toward our goal of providing more personalized care for the prevention of periodontal disease and other major human diseases,” said Mr. Carbeau. “I also look forward to working with the senior management team, all Interleukin colleagues and our provider partners to achieve our collective goal of improving patients’ lives.”

Prior to joining Interleukin, Mr. Carbeau was Co-Founder and CEO of Diagnostyx, a technology-based healthcare company focused on intelligent drug infusion systems. Prior to Diagnostyx, Mr. Carbeau served as CEO of PolyRemedy^®, a technology-enabled services business that combines health information technology with personalized therapeutics to improve wound healing outcomes.

Previously, Mr. Carbeau was the President and CEO of HyperMed, Inc., a commercial stage medical device and diagnostics company using novel hyperspectral imaging technology. Prior to HyperMed, Mr. Carbeau served as President USA of Kinetic Concepts, Inc., and successfully reinvigorated the business by growing revenues from $650 million to $950 million. Prior to that, Mr. Carbeau served as Vice President, Corporate Development at OraPharma, Inc., during its commercial launch of a periodontal therapeutic, a successful IPO, and the eventual sale of the company to Johnson & Johnson. Mr. Carbeau also founded CM Partners, a strategic life science consulting firm, and was a member of The Boston Consulting Group. Mr. Carbeau began his career serving in various sales, marketing and manufacturing roles with Eli Lilly and Company. He holds a B.S. in Industrial Engineering from Pennsylvania State University and an M.B.A. from the Wharton School of the University of Pennsylvania.

About Interleukin Genetics

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The Company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. Interleukin Genetics’ lead products include its proprietary PerioPredict^® genetic risk panel for periodontal disease and tooth loss susceptibility available through dentists, and the Inherent Health^® Weight Management Genetic Test that identifies the most effective diet program for an individual based on genetics. Interleukin Genetics is headquartered in Waltham, MA and operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratories Improvements Amendments (CLIA). For more information, please visit www.ilgenetics.com.

Forward-Looking Statements

Certain statements contained herein are “forward-looking” statements, including statements that under Mr. Carbeau’s leadership the Company will continue to grow and create value for its partners and shareholders. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those risks and uncertainties described in the Company’s annual report on Form 10-K for the year ended December 31, 2014, and other filings with the Securities and Exchange Commission. The Company disclaims any obligation or intention to update these forward-looking statements.

HOUSTON, April 9, 2015 /PRNewswire-USNewswire/ -- Representatives from Texas Children's Hospital joined an international group of medical professionals, patients and parents to determine a standard set of outcome measures for children born with cleft lip and palate. This work is the first of its kind in pediatrics on an international stage and these guidelines will help all institutions develop a standard treatment of care for this population of patients and will be available for implementation this spring. For more information visit the clinic's website, here.

The team, which was formed by The International Consortium for Health Outcomes Measurement (ICHOM), evaluated the burden of treatment and complications, including number of interventions, major surgical complications and readmissions. It also took into account the health of the patient, looking at factors like speech, oral health, eating and drinking, appearance, body weight and psychosocial functioning. In keeping with ICHOM's commitment to measuring results that matter and reporting patient outcomes in a standardized way, these guidelines will help ensure all of a patient's needs are met.

Three representatives from Texas Children's, supported by hospital leadership, took part in the esteemed program, including Dr. Laura Monson, pediatric plastic surgeon at Texas Children's Hospital and assistant professor of surgery at Baylor College of Medicine, outcomes research nurse, Christy Hernandez, from the Texas Children's Hospital Outcomes & Impact Service, and craniofacial orthodontist at Texas Children's Hospital and assistant professor of plastic surgery at Baylor College of Medicine Dr. John O. Wirthlin. The working group was comprised of members from Australia, Canada, India, Netherlands, Spain, Sweden, the UK, and the U.S., and included participants from other organizations including Boston Children's Hospital, Children's Hospital of Philadelphia and Great Ormond Street. 

"We are proud to be a part of the team that developed this important set of measures and to have collaborated with other respected medical professionals from highly esteemed institutions in this process," said Kathleen Carberry, nurse and director of Texas Children's Hospital Outcomes and Impact Service. "This work is the first of its kind and a step toward really examining the value of health care delivery from the patient's perspective."

Texas Children's has a large population of cleft lip and palate patients resulting in nearly 2,000 clinic visits and 500 surgical cases per year and the hospital will be following the new guidelines and measurements to ensure their needs are met. Texas Children's Cleft Lip and Palate Clinic already addresses many of the outcome measures listed in the ICHOM Standard Set, however it will be adding the measures of oral health, appearance and burden of care beginning in February.  

"We're looking forward to seeing these guidelines put to use here at Texas Children's, and all over the world, to ensure the best possible care for these children," said Monson, who is currently studying the short-and long-term outcomes of patients with cleft lip and palate as part of a Texas Children's Hospital Auxiliary Fellowship award she was given. "These kids need – and deserve – every possible opportunity to live a healthy, happy, and well-adjusted life, and we believe these standards will significantly improve patient outcomes."

This is not Texas Children's first step towards improving the lives of patients with cleft lip and palate. After receiving feedback from patients about the hardships they endure and the challenges they face because they look different, Texas Children's launched a weekend camp last March, designed to provide children born with cleft lip and palate the chance to be themselves, make new friendships and gain the self confidence many of them lack due to their facial abnormalities.

Texas Children's follows its cleft lip and palate patients' clinical outcomes and quality of life for 18 years, tracking the patient's speech progress, the aesthetical development of the cleft lip and palate repair, as well as the progress of the child's emotional and psychosocial healing.

"Our team's dedication doesn't just stop with the patients we are currently treating," says Wirthlin. "We are committed to tracking the progress of our kids so we can perfect the already exceptional care we provide and improve clinical outcomes for those future families that will be seeking our help down the road. Helping to create these guidelines was just one more step in bettering our patients' lives."

Malvern, PA -- April 8, 2015 – DentalEZ^®, a supplier of integrated products and services for dental health professionals worldwide, is pleased to announce two recent additions to its DentalEZ NextGen^® line of dental cabinets, the new NextGen Sterilization Center and NextGen Basic Cabinets.

The efficient design of the NextGen Sterilization Center provides the entire dental team with all necessary requirements for a seamless sterilization process in one Single Flow Center.

Features include:

Spacious upper storage cabinets equipped with luminous task lighting

Glove, soap, and towel dispenser

An equipment tower with pull-out shelves and open storage spaces

A deep drop-in sink with faucet/spray 

Tapmaster^® hands-free faucet control

Stainless steel waste drop with basket

Two enclosed pull-out surfaces for equipment

The DentalEZ NextGen Sterilization Centers are available in four Single Flow Center sizes: 72", 96", 120", or 144" and can be completely customized per size or design to fit specific practice requirements.

In addition, the new NextGen Basic Cabinet line consists of three economical workstations ergonomically designed for workflow efficiency and ease of use. The NextGen Basic Team Workstation and its left-to-right pivoting mobile work surface hold either duo or assistant only instrumentation. The thin, tapered work surface is designed for ease of use during procedures and can be conveniently moved out of the work area with an effortless left or right gliding motion. 

Other NextGen Basic Team Workstation features include:

Upper storage module with two spacious cabinets

Luminous task lighting

A built-in electrical outlet with powder-coated aluminum trim to accommodate ancillary devices

Clean water system

Easy access drop-down pull-out front shelf for additional storage.

Base drawers (optional soft close)

The NextGen Basic Doctor’s and Assistant’s Workstation (side workstation) is equipped with side cabinets that are available in a wide variety of door and drawer configurations to meet each unique practice requirement. 

Features include:

Spacious storage drawers

Convenient countertop metal trash drop

Standard single lever stainless steel faucet

Stainless steel sub-base with adjustable feet for leveling cabinets

Optional Tapmaster foot-activated faucet control

Optional soap dispenser

Optional finished back panel

The NextGen Basic Dual Access Workstation (DAWS) is a shared workstation ideal for dual open bay operatory layouts.

The Basic Dual Access Workstation is available in three models: 

DAWS Model A includes a privacy panel

DAWS Model B includes a doctor’s console

DAWS Model C includes x-ray bi-fold doors

Features of the NextGen Basic Dual Access Workstation include:

An aesthetically pleasing stainless steel shared sink section

Countertop-mounted stainless steel trash drop

Numerous storage areas including: accessory item drawers, a customized storage area (available in numerous configurations of doors and drawers), a sink plumbing area, and a trash waste area

A sub-base with adjustable feet for leveling cabinets

Spacious upper-level storage area

Easy-load glove, cup, and towel dispensers

Access panel that can be used for a cabinet-mounted light or x-ray

Tapmaster foot-activated faucet control

For more information about DentalEZ’s full line of NextGen dental cabinets, please visit www.dentalez.com. 

About DentalEZ

DentalEZ is committed to advancing the practice of dentistry through fully integrated products and services. Encompassing five distinct product categories —StarDental^®, DentalEZ, RAMVAC^®, NevinLabs™, and Columbia Dentoform^®—DentalEZ manufactures everything in the operatory, from handpieces to chairs to vacuum systems to dental simulation models, creating a complete line of products to elevate the health, comfort, and efficiency of the dental operatory. For more information, please visit www.dentalez.com. 

Algonquin, Ill. – April 7, 2015 -- Young Innovations, a leader in the dental products industry, has unveiled its newest business that will serve Original Equipment Manufacturer customers worldwide in creating high-quality dental products. The new company, Bridge2, is positioned as a single-source partner, bringing all the specialized expertise and capabilities needed to create a broad range of restorative and preventative oral care products.

Bridge2 has immediate legitimacy in the marketplace by leveraging the collective strengths, resources and an expert team of people from two of Young Innovations' industry-leading companies: Microbrush and Young Dental. Both Young Dental and Microbrush have a long history of and reputation for innovating some of the dental industry's best-selling dental products.

Bridge2 is not a typical contract manufacturer. Bridge2 wants to partner with customers as an extension of their R&D department to help them bring unique and differentiating dental products to market. Offering a full suite of capabilities, Bridge2 will work collaboratively with OEM partners from start to finish, providing creative ideation, market research, product design, prototyping, manufacturing, packaging and logistics.

In addition to its custom capabilities, Bridge2 also offers semi-custom (private-label) and off-the-shelf product.

"We want to be the go-to partner for preventative oral healthcare and restorative dental products,” said Dave Sproat, President and CEO of Young Innovations. “Our reputation for quality, the experience of our people and our full-service capabilities have enabled us to create a process that improves the product development experience and provides a better value for our partners.”

Operating exclusively within its two world-class U.S. manufacturing facilities located in Earth City, Missouri, and Grafton, Wisconsin, Bridge2's processes are sanctioned by the world's top regulatory bureaus. Bridge2 manufactures and tests its products in accordance to applicable standards of the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA). Its facilities uphold stringent quality requirements to be certified ISO 13485 and ISO 9001.

"Our people are passionate about this industry,” Sproat said. “We're excited that Bridge2 gives us the vehicle to lend our creativity, knowledge and talent to OEM partners around the world to help them make a difference not only in their business, but in the dental industry."

For more information about Bridge2, visit our website at Bridge2.dental or contact Bethany Glasenapp at +1.262.375.4011 or bglasenapp@bridge2.dental.

ATLANTA—Carestream Dental and Core3dcentres® have announced that Core3dcentres has been recognized as a Complete Solutions Partner for Carestream Dental in North America. 

Core3dcentres has undergone a rigorous training process to help CS Connect — a hosted web-based platform that enables the transmission of digital impression data — dental laboratories take maximum advantage of Carestream Dental’s CAD/CAM solutions, making their workflow intuitive and efficient, while building their business.

First, practitioners use either one of several Carestream Dental cone beam computed tomography (CBCT) units or the CS 3500 intraoral scanner to create digital impressions. With a CBCT unit, conventional impressions are scanned to create 3D models, or, the intraoral scanner can be used to capture true color, high-resolution 3D digital images of patients’ teeth.

Once the STL files have been submitted to a laboratory, two different workflows are possible depending on the laboratory’s digital capabilities, both based on the original scans taken by the practitioner with Carestream Dental scanning solutions. If the laboratory prefers to do its own case design, Core3dcentres can assist with fast model printing, eliminating the need for expensive in-laboratory model printing capabilities. In workflow option 2, Core3dcentres also can design the case for the laboratory and then print and return the models. The laboratory can choose to mill the case itself or have Core3dcentres do it for them with either workflow option.

According to a press release, both Carestream Dental and Core3dcentres are very excited by this partnership as it opens up new opportunities for the dental industry and reinforces both companies’ commitment to using the best technologies, materials, and processes available in the market today. 

Spokane, WA - The Aurum Group of Companies has announced that Rune Fisker, VP Product Strategy and Business Unit Director, Dental Lab and Dental Clinic at 3Shape, will be speaking at the upcoming Dental Technology and Business Growth Summit 2015.

A key creator and driver of 3Shape’s solution-orientated innovations, Fisker fills his presentations with concrete CAD/CAM technology methods and his vision of the future “Digital Dentistry.” He has been with 3Shape since the beginning and holds a Ph.D. from Denmark's Technical University and an executive MBA from Copenhagen Business School.

Dental professionals from across North America are invited to attend the summit from October 1-3, 2015 in Banff, Alberta. The Aurum Group has brought together a cast of game-changing leaders, innovators and visionaries for Dental Technology and Business Growth Summit 2015. Fisker will be joined by Verne Harnish (Author of #1 best-selling business book "Scaling Up"), Avi Kopelman (Founder of Cadent, Inventor of iTero, Chief Scientist of Align Technologies), Vince Barabba (Former Kodak Executive and Author of "The Decision Loom: A Design for Interactive Decision- Making in Organizations") and a diverse group of opinion leaders on applied technology and the art and discipline of entrepreneurism.

Early Bird rates are available until April 30th! Contact the Aurum Group Continuing Education Department at 1-800-363-3989 (email ce@aurumgroup.com) for more information or go to the Special Event website at www.aurumgroupsummit.com for full details.

R-dent Dental Laboratory in Memphis, Tennessee is seeking a qualified candidate to join the laboratory’s aggressive and progressive team and fill its CAD/CAM Lead Supervisor position.

Interested parties should contact Daxton Grubb, President, at 901-341-0230 or daxton@rdentlab.com.

3Shape and Henry Schein Dental have Simplified Workflow events scheduled in 4 cities over the next 3 months. The events, featuring Jonathan Ferencz, DDS, Lee Culp, CDT, and Lida Swann, DDS, will be held April 10 in South Los Angeles, California; April 24 in Atlanta, Georgia; May 15 in Las Vegas, Nevada; and May 22 in Philadelphia, Pennsylvania.

Ferencz, Culp, and Swann will discuss the many efficiencies of treatment planning through an effective digital workflow between the dentists' practice and the dental laboratory.

The course fee is $295 per attendee, and the events run from 8 a.m. - 4:30 p.m. Detailed schedules and more information are available at simplifiedworkflowevents2015.com.